GlycoMimetics Financials
| GLYC Stock | USD 0.29 0.01 3.57% |
GlycoMimetics |
Understanding current and past GlycoMimetics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of GlycoMimetics' financial statements are interrelated, with each one affecting the others. For example, an increase in GlycoMimetics' assets may result in an increase in income on the income statement.
Please note, the presentation of GlycoMimetics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, GlycoMimetics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of GlycoMimetics' management manipulating its earnings.
GlycoMimetics Stock Summary
GlycoMimetics competes with Mineralys Therapeutics,, Foghorn Therapeutics, Inventiva, Dyne Therapeutics, and Trevi Therapeutics. GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. GlycoMimetics, Inc. was incorporated in 2003 and is headquartered in Rockville, Maryland. Glycomimetics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 52 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US38000Q1022 |
| CUSIP | 38000Q102 |
| Location | Maryland; U.S.A |
| Business Address | 9708 Medical Center |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.glycomimetics.com |
| Phone | 240 243 1201 |
| Currency | USD - US Dollar |
GlycoMimetics Key Financial Ratios
GlycoMimetics Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GlycoMimetics's current stock value. Our valuation model uses many indicators to compare GlycoMimetics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GlycoMimetics competition to find correlations between indicators driving GlycoMimetics's intrinsic value. More Info.GlycoMimetics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GlycoMimetics' earnings, one of the primary drivers of an investment's value.GlycoMimetics Systematic Risk
GlycoMimetics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. GlycoMimetics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-one with a total number of output elements of fourty. The Beta measures systematic risk based on how returns on GlycoMimetics correlated with the market. If Beta is less than 0 GlycoMimetics generally moves in the opposite direction as compared to the market. If GlycoMimetics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one GlycoMimetics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of GlycoMimetics is generally in the same direction as the market. If Beta > 1 GlycoMimetics moves generally in the same direction as, but more than the movement of the benchmark.
About GlycoMimetics Financials
What exactly are GlycoMimetics Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include GlycoMimetics' income statement, its balance sheet, and the statement of cash flows. Potential GlycoMimetics investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although GlycoMimetics investors may use each financial statement separately, they are all related. The changes in GlycoMimetics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on GlycoMimetics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.GlycoMimetics February 16, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of GlycoMimetics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of GlycoMimetics. We use our internally-developed statistical techniques to arrive at the intrinsic value of GlycoMimetics based on widely used predictive technical indicators. In general, we focus on analyzing GlycoMimetics Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build GlycoMimetics's daily price indicators and compare them against related drivers.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 23.62 | |||
| Value At Risk | (9.38) | |||
| Potential Upside | 9.52 |
Complementary Tools for GlycoMimetics Stock analysis
When running GlycoMimetics' price analysis, check to measure GlycoMimetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlycoMimetics is operating at the current time. Most of GlycoMimetics' value examination focuses on studying past and present price action to predict the probability of GlycoMimetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlycoMimetics' price. Additionally, you may evaluate how the addition of GlycoMimetics to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |